Cited by 1,682Mesenchymal stem cell researchPeriodontal Regeneration and TreatmentsHematopoietic Stem Cell Transplantation

The MSC: An Injury Drugstore

Open access
Caplan, Arnold I., Correa, Diego·2011·Cell Stem Cell

Abstract

Now that mesenchymal stem cells (MSCs) have been shown to be perivascular in vivo, the existing traditional view that focuses on the multipotent differentiation capacity of these cells should be expanded to include their equally interesting role as cellular modulators that brings them into a broader therapeutic scenario. We discuss existing evidence that leads us to propose that during local injury, MSCs are released from their perivascular location, become activated, and establish a regenerative microenvironment by secreting bioactive molecules and regulating the local immune response. These trophic and immunomodulatory activities suggest that MSCs may serve as site-regulated "drugstores" in vivo.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.stem.2011.06.008

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Upon tissue damage, endogenous MSCs migrate from their perivascular location and create a regenerative microenvironment through the secretion of bioactive factors and modulation of the immune cell response.

    “upon tissue damage, endogenous MSCs migrate from their perivascular location and create a regenerative microenvironment through the secretion of bioactive factors and the modulation of the immune cell response [11], [12].”

    From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [11]

    In “The Drugstore” (page not provided), the authors propose that vessel damage releases perivascular cells, which then secrete bioactive molecules that regulate immune cells and establish a regenerative microenvironment. The citing sentence presents this proposed model as an established response to tissue damage, rather than retaining the source’s qualification. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Mesenchymal stem/stromal cells can be obtained from numerous human tissues and can differentiate into a wide variety of cell types.

    “Mesenchymal stem/stromal cells (MSCs) can be obtained from numerous human tissues and can differentiate into a wide variety of cell types [15].”

    From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [15]

    The Mesenchymal Stem Cell (MSC) section reports isolation from human bone marrow and describes adipose-derived cells; The Drugstore section also discusses MSCs from fat, placenta, umbilical cord and muscle. The paper documents differentiation into multiple mesenchymal lineages in vitro, but says that in vivo multipotency is not definitive. The claim omits those limits when it says MSCs can differentiate into a wide variety of cell types. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 49

  1. Bai L Lennon DP Eaton V Maier K Caplan AI Miller SD Miller RH 2009 Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis Glia 57 1192 1203 19191336 PMC2706928
  2. Baksh D Song L Tuan RS 2004 Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy J Cell Mol Med 8 301 316 15491506 PMC6740223
  3. Bianco P Robey PG Simmons PJ 2008 Mesenchymal stem cells: revisiting history, concepts, and assays Cell Stem Cell 2 313 319 18397751 PMC2613570
  4. Bonfield TL Koloze M Lennon DP Zuchowski B Yang SE Caplan AI 2010 Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model Am J Physiol Lung Cell Mol Physiol 299 L760 70 20817776 PMC4116401
  5. Bruder SP Jaiswal N Haynesworth SE 1997 Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation J Cell Biochem 64 278 294 9027588
  6. Caplan AI 1991 Mesenchymal stem cells J Orthop Res 9 641 650 1870029
  7. Caplan AI 1994 The Mesengenic Process Clinics in Plastic Surgery 21 429 435 7924141
  8. Caplan AI 2008 All MSCs are pericytes? Cell Stem Cell 3 229 230 18786406
  9. Caplan AI 2010 What’s in a name? Tissue Eng Part A 16 2415 2417 20412005
  10. Caplan AI Dennis JE 2006 Mesenchymal stem cells as trophic mediators J Cell Biochem 98 1076 1084 16619257
  11. Colter DC Class R DiGirolamo CM Prockop DJ 2000 Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow Proc Natl Acad Sci U S A 97 3213 3218 10725391 PMC16218
  12. Dennis JE Merriam A Awadallah A Yoo JU Johnstone B Caplan AI 1999 A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse J Bone Miner Res 14 700 709 10320518
  13. Diaz-Flores L Gutierrez R Madrid JF Varela H Valladares F Acosta E Martin-Vasallo P Diaz-Flores LJ 2009 Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche Histol Histopathol 24 909 969 19475537
  14. Friedenstein AJ Chailakhyan RK Gerasimov UV 1987 Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers Cell Tissue Kinet 20 263 272 3690622
  15. Friedenstein AJ Piatetzky-Shapiro II Petrakova KV 1966 Osteogenesis in transplants of bone marrow cells J Embryol Exp Morphol 16 381 390 5336210
  16. Giordano A Galderisi U Marino IR 2007 From the laboratory bench to the patient’s bedside: an update on clinical trials with mesenchymal stem cells J Cell Physiol 211 27 35 17226788
  17. Gonzalez-Rey E Anderson P Gonzalez MA Rico L Buscher D Delgado M 2009 Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis Gut 58 929 939 19136511
  18. Guilak F Estes BT Diekman BO Moutos FT Gimble JM 2010 2010 Nicolas Andry Award: Multipotent adult stem cells from adipose tissue for musculoskeletal tissue engineering Clin Orthop Relat Res 468 2530 2540 20625952 PMC2919887
  19. Hall BK 2008 The neural crest and neural crest cells: discovery and significance for theories of embryonic organization J Biosci 33 781 793 19179766
  20. Hass R Kasper C Bohm S Jacobs R 2011 Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC Cell Commun Signal 9 12 21569606 PMC3117820
  21. Hirschi KK D’Amore PA 1996 Pericytes in the microvasculature Cardiovasc Res 32 687 698 8915187
  22. Horwitz EM Le Blanc K Dominici M Mueller I Slaper-Cortenbach I Marini FC Deans RJ Krause DS Keating A 2005 Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement Cytotherapy 7 393 395 16236628
  23. Itescu S Schuster MD Kocher AA 2003 New directions in strategies using cell therapy for heart disease J Mol Med 81 288 296 12698252
  24. Iyer SS Rojas M 2008 Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies Expert Opin Biol Ther 8 569 581 18407762
  25. Jones BJ McTaggart SJ 2008 Immunosuppression by mesenchymal stromal cells: from culture to clinic Exp Hematol 36 733 741 18474304
  26. Koc ON Day J Nieder M Gerson SL Lazarus HM Krivit W 2002 Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) Bone Marrow Transplant 30 215 222 12203137
  27. Krasnodembskaya A Song Y Fang X Gupta N Serikov V Lee JW Matthay MA 2010 Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37 Stem Cells 28 2229 2238 20945332 PMC3293245
  28. Lazarus HM Haynesworth SE Gerson SL Rosenthal NS Caplan AI 1995 Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use Bone Marrow Transplant 16 557 564 8528172
  29. Le Blanc K Frassoni F Ball L Locatelli F Roelofs H Lewis I Lanino E Sundberg B Bernardo ME Remberger M Dini G Egeler RM Bacigalupo A Fibbe W Ringden O 2008 Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study Lancet 371 1579 1586 18468541
  30. Le Blanc K Tammik L Sundberg B Haynesworth SE Ringden O 2003 Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex Scand J Immunol 57 11 20 12542793
  31. Mackay AM Beck SC Murphy JM Barry FP Chichester CO Pittenger MF 1998 Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow Tissue Eng 4 415 428 9916173
  32. Majumdar MK Thiede MA Mosca JD Moorman M Gerson SL 1998 Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells J Cell Physiol 176 57 66 9618145
  33. Meirelles Lda S Fontes AM Covas DT Caplan AI 2009 Mechanisms involved in the therapeutic properties of mesenchymal stem cells Cytokine Growth Factor Rev 20 419 427 19926330
  34. Miller RH Bai L Lennon DP Caplan AI 2010 The potential of mesenchymal stem cells for neural repair Discov Med 9 236 242 20350491
  35. Minguell JJ Erices A 2006 Mesenchymal stem cells and the treatment of cardiac disease Exp Biol Med (Maywood) 231 39 49 16380643
  36. Moretti P Hatlapatka T Marten D Lavrentieva A Majore I Hass R Kasper C 2010 Mesenchymal stromal cells derived from human umbilical cord tissues: primitive cells with potential for clinical and tissue engineering applications Adv Biochem Eng Biotechnol 123 29 54 20012739
  37. Owen M Friedenstein AJ 1988 Stromal stem cells: marrow-derived osteogenic precursors CIBA Found Symp 136 42 60 3068016
  38. Pittenger MF Mackay AM Beck SC Jaiswal RK Douglas R Mosca JD Moorman MA Simonetti DW Craig S Marshak DR 1999 Multilineage potential of adult human mesenchymal stem cells Science 284 143 147 10102814
  39. Prockop DJ 1997 Marrow stromal cells as stem cells for nonhematopoietic tissues Science 276 71 74 9082988
  40. Rehman J Traktuev D Li J Merfeld-Clauss S Temm-Grove CJ Bovenkerk JE Pell CL Johnstone BH Considine RV March KL 2004 Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells Circulation 109 1292 1298 14993122
  41. Ringden O Uzunel M Rasmusson I Remberger M Sundberg B Lonnies H Marschall HU Dlugosz A Szakos A Hassan Z Omazic B Aschan J Barkholt L Le Blanc K 2006 Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease Transplantation 81 1390 1397 16732175
  42. Rodeheffer MS Birsoy K Friedman JM 2008 Identification of white adipocyte progenitor cells in vivo Cell 135 240 249 18835024
  43. Sacchetti B Funari A Michienzi S Di Cesare S Piersanti S Saggio I Tagliafico E Ferrari S Robey PG Riminucci M Bianco P 2007 Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment Cell 131 324 336 17956733
  44. Schuster MD Kocher AA Seki T Martens TP Xiang G Homma S Itescu S 2004 Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration Am J Physiol Heart Circ Physiol 287 H525 32 15277196
  45. Singer NG Caplan AI 2011 Mesenchymal stem cells: mechanisms of inflammation Annu Rev Pathol 6 457 478 21073342
  46. Tang W Zeve D Suh JM Bosnakovski D Kyba M Hammer RE Tallquist MD Graff JM 2008 White fat progenitor cells reside in the adipose vasculature Science 322 583 586 18801968 PMC2597101
  47. Tavassoli M Crosby WH 1968 Transplantation of marrow to extramedullary sites Science 161 54 56 4871792
  48. Traktuev DO Merfeld-Clauss S Li J Kolonin M Arap W Pasqualini R Johnstone BH March KL 2008 A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks Circ Res 102 77 85 17967785
  49. Wagner J Kean T Young R Dennis JE Caplan AI 2009 Optimizing mesenchymal stem cell-based therapeutics Curr Opin Biotechnol 20 531 536 19783424

Cited by

Sorted by citations

Authors
Caplan, A. I., & Correa, D.
Affiliations
Case Western Reserve University (US)
Corresponding author
Caplan, Arnold I.
Venue
Cell Stem Cell
Publisher
Elsevier BV
Published
2011-07
Volume
9
Issue
1
Pages
11-15
ISSN
  • 1875-9777 (ISSN-L)
  • 1934-5909
OpenAlex
W2018258390
Cited by
1,682
References
3
Citations by year
2026: 80 · 2025: 87 · 2024: 85 · 2023: 105 · 2022: 104 · 2021: 155 · 2020: 147 · 2019: 130 · 2018: 137 · 2017: 122 · 2016: 144 · 2015: 135 · 2014: 96 · 2013: 85 · 2012: 60
FWCI
40.74
Type
journal article
Language
en
Open access
Locations
  • Cell stem cell (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Arthritis and Musculoskeletal and Skin Diseases (P01AR053622)
Topics
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Health Sciences › Medicine › Urology › Periodontal Regeneration and Treatments
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords
mesenchymal stem cells, perivascular localization, injury response, immunomodulation, regenerative microenvironment, trophic activity, local immune response, stem cell activation
MeSH terms
Animals, Clinical Trials as Topic, Humans, Treatment Outcome, Pericytes, Models, Animal, Mesenchymal Stem Cells, Cell- and Tissue-Based Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review